Current challenges in the risk assessment of neuraminidase inhibitor-resistant influenza viruses

J Infect Dis. 2010 Mar;201(5):656-8. doi: 10.1086/650465.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Disease Models, Animal
  • Drug Resistance, Viral*
  • Ferrets
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza, Human / drug therapy*
  • Mice
  • Neuraminidase / antagonists & inhibitors*
  • Orthomyxoviridae Infections / drug therapy
  • Risk Assessment

Substances

  • Antiviral Agents
  • Neuraminidase